Letters to the Editor

Use of Intravenous Colchicine for Podagra


Am Fam Physician. 1999 Dec 1;60(9):2504-2507.

to the editor: I would like to offer a few comments on the article by Pittman and Bross1 on the diagnosis and management of gout.

It is nice to see that the authors recommend intravenous colchicine for the relief of podagra. The use of this agent represents one of those “dramatic” moments in clinical medicine. The patient hobbles into the examining room in acute pain and walks out just minutes later with almost total relief.

This dramatic relief of pain after administration of colchicine is also an important diagnostic clue in gout—and the thought of injecting an acutely inflamed joint to aspirate diagnostic synovial fluid to look for urate crystals . . . well, just the thought gives one real pause.

Intravenous colchicine is not only helpful therapeutically, it is also helpful diagnostically.


1. Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician. 1999;59:1799–1806.

Send letters to afplet@aafp.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.

Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.



Copyright © 1999 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


May 2022

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article